FDA grants priority review Elite Pharmaceuticals’ SequestOX NDA
The FDA has set a target action date under the Prescription Drug User Fee Act ("PDUFA") of July 14, 2016. SequestOxTM is an immediate-release Oxycodone Hydrochloride containing sequestered